Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R I Tepper

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Human Gene Therapy|February 1, 1994
Experimental and clinical studies of cytokine gene-modified tumor cellsR I Tepper, J J Mulé
Cellular Immunology|December 1, 1994
IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivoL Wang, E Goillot, R I Tepper
Science (New York, N.Y.)|July 24, 1992
An eosinophil-dependent mechanism for the antitumor effect of interleukin-4R I Tepper, R L Coffman, P Leder
Cell|May 5, 1989
Murine interleukin-4 displays potent anti-tumor activity in vivoR I Tepper, P K Pattengale, P Leder
Nature Genetics|August 1, 1995
Gene therapy of metastatic cancer by in vivo retroviral gene targetingR K Hurford, G Dranoff, R C Mulligan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991
Humoral immune functions in IL-4 transgenic miceH J Burstein, R I Tepper, P Leder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1997
T cell-derived IL-10 antagonizes macrophage function in mycobacterial infectionP J Murray, L Wang, C Onufryk, et al.
The Journal of Experimental Medicine|February 1, 1993
Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic miceB E Rich, J Campos-Torres, R I Tepper, et al.
Cancer Research|July 1, 1993
Treatment of glioma by engineered interleukin 4-secreting cellsJ S Yu, M X Wei, E A Chiocca, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1997
Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathwayE Goillot, J Raingeaud, A Ranger, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Human Gene Therapy|February 1, 1994
Experimental and clinical studies of cytokine gene-modified tumor cellsR I Tepper, J J Mulé
Cellular Immunology|December 1, 1994
IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivoL Wang, E Goillot, R I Tepper
Science (New York, N.Y.)|July 24, 1992
An eosinophil-dependent mechanism for the antitumor effect of interleukin-4R I Tepper, R L Coffman, P Leder
Cell|May 5, 1989
Murine interleukin-4 displays potent anti-tumor activity in vivoR I Tepper, P K Pattengale, P Leder
Nature Genetics|August 1, 1995
Gene therapy of metastatic cancer by in vivo retroviral gene targetingR K Hurford, G Dranoff, R C Mulligan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991
Humoral immune functions in IL-4 transgenic miceH J Burstein, R I Tepper, P Leder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1997
T cell-derived IL-10 antagonizes macrophage function in mycobacterial infectionP J Murray, L Wang, C Onufryk, et al.
The Journal of Experimental Medicine|February 1, 1993
Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic miceB E Rich, J Campos-Torres, R I Tepper, et al.
Cancer Research|July 1, 1993
Treatment of glioma by engineered interleukin 4-secreting cellsJ S Yu, M X Wei, E A Chiocca, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1997
Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathwayE Goillot, J Raingeaud, A Ranger, et al.
Pageof 2